Carl Gordon
Angel · California
Board director at 8 startups that filed Form D raises since late 2024, mostly in California.
- Stages
- Series B, Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Oct 2025
Focus
Biotech & PharmaRecent portfolio activity
- Oct 2025
Star Therapeutics
Board seat · CA
- Sep 2025
Avenzo Therapeutics
Board seat · CA
- Nov 2024
Lomond Therapeutics Holdings
Board seat · DE
- Jul 2024
Belenos Biosciences
Board seat · NY
- Jan 2024
BlossomHill Therapeutics
Board seat · CA
- Dec 2023
Odyssey Therapeutics
Board seat · MA
- Feb 2023
Garuda Therapeutics
Board seat · MA
- Jan 2023
ADARx Pharmaceuticals
Board seat · CA
Sources
- SEC Form D: ADARx PharmaceuticalsJan 26, 2023
- SEC Form D: Garuda TherapeuticsFeb 3, 2023
- SEC Form D: Odyssey TherapeuticsDec 15, 2023
- SEC Form D: BlossomHill TherapeuticsJan 2, 2024
- SEC Form D: Avenzo TherapeuticsSep 5, 2025
- SEC Form D: Belenos BiosciencesJul 17, 2024
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.